T23 Biopharmaceutical
T23 is pre-clinical and clinical stage biopharmaceutical Company.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed T23 Biopharmaceutical Information
Geographic Data
Address: 6605 Nancy Ridge Drive Ste 207
City: San Diego
State: CA
Zip: 92121
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
T23 is pre-clinical and clinical stage biopharmaceutical Company. Located at Torrey Pines Investment campus in San Diego, CA it is focused on development of novel targeted immunotherapies for treatment of patients with cancer and autoimmune disease. T101, their candidate conjugate of siglec ligand and nanosomal formulation is currently in pre-clinical development with other conjugates in discovery.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2014 | Venture Round | 1 | - |
Torrey Pines Investment Torrey Pines Investment |
6/2014 | Venture Round | 1 | - |
Torrey Pines Investment Torrey Pines Investment |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
